The indications approved for Adacolumn® in Europe are inflammatory bowel disease, obviously, ulcerative colitis and Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, lupus and SLE (systemic lupus erythematosus). The indication for inflammatory bowel disease includes both ulcerative colitis and Crohn’s disease in induction and maintenance.
References:
- Instrucciones de uso de Adacolumn®
- J.L. Cabriada, E. Doménech, F. Gomollón, P. González-Carro, V. González-Lara, J. Hinojosa, C.E. Jiménez-López, P. Nos, A. Obrador, J. Panès, C. Saro, V. Varea, R. Lafuente, M. Guilera, Documento de consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal, Gastroenterología y Hepatología, Volume 29, Issue 2, 2006, Pages 85-92, ISSN 0210-5705.
Contact UsFor more information
Contact Us